Sort by
Refine Your Search
-
, and may be extended to a second year upon successful performance and funding availability. An ideal anticipated start date is between August – December 2026, but can be arranged to suit the candidate
-
preparation. DUTIES AND RESPONSIBILITIES: 1. Designing, performing, and/or overseeing experiments and data collection. 2. Conduct a wide range of complex experiments with a degree of independence in conducting
-
fast-paced research environment and will be responsible for the development of novel research methods, will conduct experiments using in-vitro and in-vivo approaches, will perform project planning, data
-
transit as well as Gaia/LSST discoveries. Indiana University also provides excellent research computing resources (high-performance computing clusters, large-scale storage, and advanced visualization
-
, including full access to various supercomputers and massive data storage systems (see here for further details https://uits.iu.edu/services/technology-for-research/high-performance-computing-and-storage
-
(mouse) handling/manipulations: Perform surgeries/implantations (will train), biopsies, bioluminescence imaging, and drug administration. Extensive tissue culture required. Flow cytometry and microscopy
-
or 2 years based on performance. Applications, including a CV, a statement of research interests, and three letters of reference, should be submitted through the application portal located at: https
-
scientific journals. Applicants must demonstrate the ability to perform the essential functions of the job as outlined in the position description. Department Contact for Questions Grayce Beach grbeach@iu.edu
-
expectation of renewal for a second year based on performance and funding Application Instructions Interested individuals should apply at https://indiana.peopleadmin.com/postings/31525. A complete application
-
. The initial appointment for this position will be for 2 years. Additional 1 year extension will be available based on performance, mutual agreement, and funding availability of the phase II